Upload File

the harmonization process from the reneb … · abend et al. radiation research 2016, ainsbury et...

  • Home
  • Documents
  • The harmonization process from the RENEB … · Abend et al. Radiation Research 2016, Ainsbury et al. IJRB 2016, Grégoire et al. IJRB 2016, Manning et al. IJRB 2016, Rothkamm et
1
EC FP7, GA 295513 Biomarkers ranking Dicentric assay: DCA Translocation analysis : FISH Assay Micronucleus Assay : MN Laurence Roy 1 , Liz Ainsbury 2 , Christophe Badie 2 , Leonardo Barrios 3 , Céline Bassinet 1 , Paola Fattibene 4 , Eric Gregoire 1 , Ursula Oestreicher 5 , Gabriel Pantelias 6 , Sisko Salomaa 7 , Georgia Terzoudi 6 , Francois Trompier 1 , Anne Vral 8 , Andrzej Wojcik 9 , Ulrike Kulka 5 1 Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France 2 Public Health England, CRCE, Chilton, Didcot, Oxon, United Kingdom 3 Universitat Autonoma de Barcelona, Barcelona, Spain 4 Istituto di Superiore di Sanità, Rome, Italy 5 Bundesamt fuer Strahlenschutz, Department Radiation Protection and Health, Oberschleissheim, Germany 6 National Centre for Scientific Research "Demokritos", Athens, Greece 7 University of Eastern Finland, Kuopio, Finland 8 Faculty of Medicine and Health Sciences, Ghent University, Gent, Belgium 9 Stockholm University, Institute Molecular Biosciences, Stockholm, Sweden The harmonization process from the RENEB operational biological and physical retrospective dosimetry network to new biomarker validation. www.reneb.eu Background European Network for fast individual dose estimation in large scale scenarios EU project: 1.1.2012 – 31.12.2015 Established network: since 01.01.2016 Sensitivity Specificity Reporting time and capacity Time persistance L1 L2 L3 L4 L5 L6 L5 L7 L8 L9 L10 L11 L12 L13 L14 L15 Training Scientific visits Interlaboratory comparisons (ILC) Quality manual, documentation On going activities: - DCA: ILC on 500 cells in collaboration with EURADOS - FISH : homogenity in the scoring process - MN: improuvent of the staining Newly investigated 1 2 3 4 5 6 7 Gene expression assay Telomere Centromere γ-H2AX foci analysis RAMAN spectroscopy 2 institutions trained 9 institutions trained OSL: 5 institutions trained No training No training No training OSL: several ILC. Electronic components: Difficulties to identify the relevant components EPR: variability of material response Perform a standard ILC analysis and identify the parameters affecting the results Image and slides sharing. Z test passed successfully for several set of samples ILC on blood samples shipment not yet performed Some good candidates have been successfully used in ILC Effect of transportation conditions tested To be validated on in vivo exposed populations Involved in a large ILC Just one lab performing the assay up to now Two doses out of 4 have been correctly estimated Identification of the parameters affecting the results New ILC with more labs involved ILC carried out by dicentric scoring on images. Homogeneous results. Promising approach for highly accurate biodosimetry” ILC on slides and blood samples to be performed. Standard Z test to be used Abend et al. Radiation Research 2016, Ainsbury et al. IJRB 2016, Grégoire et al. IJRB 2016, Manning et al. IJRB 2016, Rothkamm et al. Radiation Research 2013, Terzoudi et al. IJRB 2016, CHO PCC Assay“ MAD: not as good as other biomarkers Has been successfully used in case of simulated partial body exposure Antibody validation process to be implemented in routine Glass: EPR and TL Electronic compo- nents: OSL and TL References Operational biomarkers Under validation L1 L2 L3 L4 L5 L6 L5 L7 L8 L9 L10 L11 L12 L13 L14 L15 Gene expression g-H2AX Dicentrics Micronuclei PCC Dicentrics OSL/TL OSL/TL g-H2AX PCC OSL/TL Dicentrics Raman Under investigation: Translocations

Upload: others

Post on 02-Jun-2020

1 views

Category:

Documents


0 download

Report

TRANSCRIPT

Page 1: The harmonization process from the RENEB … · Abend et al. Radiation Research 2016, Ainsbury et al. IJRB 2016, Grégoire et al. IJRB 2016, Manning et al. IJRB 2016, Rothkamm et

EC FP7, GA 295513

Biomarkers ranking

Dicentricassay: DCA

Translocationanalysis :

FISH Assay

MicronucleusAssay : MN

Laurence Roy1, Liz Ainsbury2, Christophe Badie2, Leonardo Barrios3, Céline Bassinet1, Paola Fattibene4,

Eric Gregoire1, Ursula Oestreicher5, Gabriel Pantelias6, Sisko Salomaa7, Georgia Terzoudi6, Francois Trompier1,

Anne Vral8, Andrzej Wojcik9, Ulrike Kulka5

1 Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France

2 Public Health England, CRCE, Chilton, Didcot, Oxon, United Kingdom

3 Universitat Autonoma de Barcelona, Barcelona, Spain

4 Istituto di Superiore di Sanità, Rome, Italy

5 Bundesamt fuer Strahlenschutz, Department Radiation Protection and Health, Oberschleissheim, Germany

6 National Centre for Scientific Research "Demokritos", Athens, Greece

7 University of Eastern Finland, Kuopio, Finland

8 Faculty of Medicine and Health Sciences, Ghent University, Gent, Belgium9 Stockholm University, Institute Molecular Biosciences, Stockholm, Sweden

The harmonization process from the RENEB

operational biological and physical

retrospective dosimetry network

to new biomarker validation.

www.reneb.eu

Background European Network for fast individual dose estimationin large scale scenarios

EU project: 1.1.2012 – 31.12.2015Established network: since 01.01.2016

Sensitivity Specificity Reporting time

and capacityTime

persistance

L1

L2

L3

L4

L5

L6

L5

L7

L8

L9L10

L11

L12

L13

L14

L15

Training Scientific visits Interlaboratory comparisons (ILC) Quality manual, documentation On going activities:

- DCA: ILC on 500 cells in collaboration with EURADOS- FISH : homogenity in the scoring process- MN: improuvent of the staining

Newly investigated

1 2 3 4 5 6 7Gene expression assay Telomere Centromereγ-H2AX foci analysis RAMAN spectroscopy

2 institutions trained

9 institutions trained

OSL: 5institutions trained

No training No training No training

OSL: several ILC. Electronic components: Difficulties to identify the relevant componentsEPR: variability of material response

Perform a standard ILC analysis and identify the parameters affecting the results

Image and slides sharing.Z test passed successfully for several set of samples

ILC on blood samples shipment not yet performed

Some good candidates have been successfully used in ILCEffect of transportation conditions tested

To be validated on in vivo exposed populations

Involved in a large ILCJust one lab performing the assay up to nowTwo doses out of 4 have been correctly estimated

Identification of the parameters affecting the resultsNew ILC with more labs involved

ILC carried out by dicentricscoring on images. Homogeneous results. Promising approach for highly accurate biodosimetry”

ILC on slides and blood samples to be performed.Standard Z test to be used

Abend et al. Radiation Research 2016, Ainsbury et al. IJRB 2016, Grégoire et al. IJRB 2016, Manning et al. IJRB 2016, Rothkamm et al. Radiation Research 2013, Terzoudi et al. IJRB 2016,

CHO PCC Assay“

MAD: not as good as other biomarkersHas been successfully used in case of simulated partial body exposure

Antibody validation process to be implemented in routine

Glass:EPRand TL

Electronic compo-nents: OSL and TL

References

Operational biomarkers

Under validation

L1

L2

L3L4

L5

L6

L5

L7

L8

L9L10

L11

L12

L13

L14

L15

Gene expression

g-H2AX

DicentricsMicronuclei

PCC

Dicentrics

OSL/TL

OSL/TL

g-H2AX PCCOSL/TL Dicentrics Raman

Under

investigation:Translocations

http://www.reneb.eu/

CryoEM Structure of CtBP2 Confirms Tetrameric Architecture · (Nardini et al., 2003; Thio et al., 2004; Nardini et al., 2009; Bi et al., 2018; Mani-Telang et al., 2007; Dcona et al.,

6 Journal research area: Whole Plant and Ecophysiology et al., 1998; Hemamalini et al., 2000; Li et al., 2001; Xing et al., 2002; Courtois et al., 2003; Xu 123 et al., 2004; Lian et

Cioca Et Al v Rumsfeld Et Al

Espinoza Et Al v. Tigchelaar Et Al

Edinburgh Research Explorer€¦ · 62 et al., 2005; Costa et al., 2008; Wedley et al., 2011) and sick dogs (Carattoli et al., 2005; Pomba et 63 al., 2009; Gibson et al., 2011a),

Faibles doses, médecine nucléaire et radiobiologie · Joubert et al. Int J Radiat Biol, 2008 Granzotto et al., IJROBP, 2016 Bodgi and Foray, IJRB, 2016 60 Cliniciens 23 CLCC ou

Unsteady Hydrodynamic Modeling of a Cycloidal PropellerBenedict et al 2014a, Benedict et al 2014b, Zachary et al 2013, Shrestha et al 2012, Shrestha et al 2014, Hrishikeshavan et al

Actin-based propulsive forces and myosin-II-based ... · Tsujioka et al. (Tsujioka et al., 2004), Ladam et al. (Ladam et al., 2005) and del Alamo et al. (del Alamo et al., 2007)

Silver et al. v. Pueblo et al

USA, Et Al v. Kaplan, Et Al

(12) United States Patent (io) · Sevcik et al. Ryanetal..... 144/154.5 Govindaraj et al. Kennedy et al. Malone Woods et al. Takahashi et al. Dick et al. Ceroll et al. Caron et al

Lung Cancer Integration of PET in Radiation Planning2011.radiologen-im-netz.de/PDF/Sa18Schmuecking.pdf · 2011-09-19 · Schmuecking et al. IJRB 2009; 85: 814-24 Prostatakarzinom:

(12) United States Patent (10) Patent No.: US 9,120,245 B1 ...Polikarpus et al. Pham et al. Bawendi et al. Bagger et al. Masuzawa et al. Conley et al. Mardilovich Higuchi et al. Kobayashi

EXHIBIT A2 - cases.justia.com · 811996 Konrad 1211996 Koppolu et al. 211997 Duscher et al. 311997 Koppolu et al. 511997 Koppolu et al. 711997 Ashe et al. 511998 Koppolu et al. 911998

et al., et al. , et al. et al

Garber et al v. MLB et al

Literature Review Messent et al (1998,1999) Robertson et al (2000) Beart et al (2001) Heller et al (2002)

(12) United States Patent (10) Patent No.: US 7895.275 B1 ... Gutta et al. Signes et al. Hashimoto et al. Ghashghai et al. Ting et al. Vaidyanathan et al. Obradovich Larsson et al

€¦ · en la IJrb. Pamplona Baja. [.ote Pqel, se encuentra cedido en uso parcial a tävor de la Organización Perú — Xiñez. por quince ( 15) años. de acuerdo al Convenio firmado

Quaternary evolution of the Caravelas strandplain – …Dominguez et al. 1998). (Suguio et al. 1985, Martin et al. 1987, 1988, Suguio et al. 1988, Martin et al. 2002). Martin et al

et al. et al

Novel Approaches to Targeting Tumour Growth IRRS Sept 2012 for publication.pdf · al IJRB 2000; Jascur et al, Mol Cell 2005) FKBPL FKBPL/ DIR1 ER Modulation of ER signalling, inhibition

EXHIBIT E - cases.justia.com · 811996 Konrad 1211996 Koppolu et al. 211997 Duscher et al. 311997 Koppolu et al. 511997 Koppolu et al. 711997 Ashe et al. 511998 Koppolu et al. 911998

Multi-scale assessment of human-induced changes to ... · (Neill et al. 2001; Davidson et al. 2004; Neill et al. 2006; Figueiredo et al. 2010; Neill et al. 2011; Macedo et al. 2013;

Sin título-1 · dif municipal ijrb dif municipal urb presidencia municipal prlsidlncia municipal municipal prlsidencia municipal sindicalia mlinicipal sinoicalia particular coor

Integrative analysis of multi-platform RPPA data · 2011, Hayashi et al. 2014, Bernhardt et al. 2017, Hutter et al. 2017, Lièvre et al. 2017, Aslan et al. 2018, Faham et al. 2018,

responses and low dose exposure: evidence and …...Bauer et al., 2009 IJRB 83.873. Interactions between transformed and non-transformed cells • Transformed cells can be triggered

Smartflash Et. Al. v. Google Et. Al

, et al. Petitioners, et al. Respondents

et al. 2015 Cultural... · Bain (1986) Morton et al. (1986) Bowles et al. (1988) Graham & Noonan (2010) Kremers et al. (2012) Crance et al. (2014) Musser et al. (2014) Topic Geographic

Oceana et al vs.BOEM et al

Mutanwad et al., 2019 · signaling (Swain et al. 2001; Tseng et al. 2001; Silverstone et al. 2007; Zentella et al. 2016; Zentella et al. 2017). One of the most prominent features

The human genome Lander et al. 2001 Venter et al. 2001 Patil et al. 2001 Gabriel et al. 2002 Reich et al. 2001 Sabeti et al. 2002 Yu et al. 2002

(12) United States Patent (10) Patent No.: US 6,792,177 B2 ...Gale et al. Asakura Neukermans et al. Laor Pan et al. Laughlin Hornbeck Gove et al. Neukermans et al. Neukermans et al

Turkmen, et al. v. Hasty, et al